AT-HOME PREVENTION PANEL
At-Home Prevention Panel
One revolutionary testing solution to identify and test at-risk populations for prediabetes, diabetes, chronic kidney disease, cardiovascular disease and hepatitis C.
Have the Disease
*According to the Centers for Disease Control.
Test for 5 of the costliest, deadliest, most underdiagnosed diseases in the US
Identify and manage risk earlier in disease progression
See clinical outcomes in real-time
BioIQ's Digital Platform
BioIQ combines artificial intelligence, population insights, and assistive care navigation with a broad network of fully integrated healthcare services onto one technology platform to enable our clients to achieve their goals.
Advanced program management with recommendations and insights down to the participant level.
Analytics + AI
Health and consumer data provide actionable insights to optimize how we reach and engage people.
A world-class telemedicine solution that scales across the medical ecosystem.
Convenient Care Options
Meet individuals where they are with personalized, convenient at-home programs.
Engage each individual to take action with personalized omnichannel participant activation campaigns – text, email, IVR, mail, live outreach.
Support team dedicated to handle customer service and program management.
Enable participants to take control of their health by accessing digital healthcare services; completing lab tests and viewing results from the comfort of their home.
Web Portal and Mobile App
Our web portal and mobile app provide a world-class digital experience for participants.
Digital Test Results
Digital test results can be viewed, downloaded and shared.
Telehealth platform provides high-quality care, appointment scheduling and reminders from the safety and comfort of their homes.
Secure Kit Activation
Test kits are activated using our secure web portal or mobile app.
Multiple tests are completed using a single finger-stick.
Health Content Library
State-of-the-art health content designed for the new digital world.
Health plans need modern solutions for screening members that are safe, scalable, and convenient in order to provide the preventative care their members need.
BioIQ provides a modern approach to member wellness with our At-Home Prevention Panel, a simple, self-administered fingerstick blood test which members can complete from the comfort and safety of their home.
This single panel tests the member for Prediabetes, Diabetes, Kidney Disease, Cardiovascular Disease, and Hepatitis C.
The Prevention Panel is a turn-key disease surveillance solution to test at-risk populations and refer identified individuals into the appropriate follow-up care or disease management program. This ultimately impacts cost and outcomes through early identification and intervention of these diseases.
The At-Home Prevention Panel Tests
Hemoglobin A1c is used to test a person’s average blood sugar over the past 3 months. Elevated levels are associated with higher blood sugar levels and can be used to screen for pre-diabetes and diabetes.
Blood fats like cholesterol, Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), and triglycerides can be used to determine risk for heart attacks and stroke.
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). It´s recommend for at least once in a lifetime for all adults aged 18 years and older.
Serum Creatinine + EGFR
This test is used to evaluate kidney function. A measure of creatinine and eGFR is a calculation that determines how well the blood is filtered by the kidneys, which is one way to measure remaining kidney function. EGFR can also used to find the stage of chronic kidney disease.
Why Partner with BioIQ?
We coordinate every aspect of your program from design to communications and results reporting.
A true partner that assumes risk so that clients pay for what matters: outcomes.
Our extensive ecosystem of healthcare partners delivers care where it is most convenient at scale.
Ready to learn more?
Subscribe to The Result
Our monthly newsletter for insights insights, evidence and guidance from BioIQ's data powered network